Nothing Special   »   [go: up one dir, main page]

FI981777A0 - Farmaseuttinen ainekoostumus - Google Patents

Farmaseuttinen ainekoostumus

Info

Publication number
FI981777A0
FI981777A0 FI981777A FI981777A FI981777A0 FI 981777 A0 FI981777 A0 FI 981777A0 FI 981777 A FI981777 A FI 981777A FI 981777 A FI981777 A FI 981777A FI 981777 A0 FI981777 A0 FI 981777A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
FI981777A
Other languages
English (en)
Swedish (sv)
Other versions
FI981777A (fi
Inventor
Friedrich Richter
Michel Steiger
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26298929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI981777(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB919110884A external-priority patent/GB9110884D0/en
Priority claimed from GB919111477A external-priority patent/GB9111477D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of FI981777A publication Critical patent/FI981777A/fi
Publication of FI981777A0 publication Critical patent/FI981777A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Lubricants (AREA)
FI981777A 1991-05-20 1998-08-18 Farmaseuttinen ainekoostumus FI981777A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919110884A GB9110884D0 (en) 1991-05-20 1991-05-20 Pharmaceutical compositions
GB919111477A GB9111477D0 (en) 1991-05-29 1991-05-29 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
FI981777A FI981777A (fi) 1998-08-18
FI981777A0 true FI981777A0 (fi) 1998-08-18

Family

ID=26298929

Family Applications (2)

Application Number Title Priority Date Filing Date
FI922252A FI102458B1 (fi) 1991-05-20 1992-05-18 Menetelmä topikaalisen farmaseuttisen koostumuksen valmistamiseksi
FI981777A FI981777A0 (fi) 1991-05-20 1998-08-18 Farmaseuttinen ainekoostumus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FI922252A FI102458B1 (fi) 1991-05-20 1992-05-18 Menetelmä topikaalisen farmaseuttisen koostumuksen valmistamiseksi

Country Status (29)

Country Link
US (2) US5681849A (fi)
EP (1) EP0515310B1 (fi)
JP (1) JP2651311B2 (fi)
KR (1) KR100303095B1 (fi)
AT (1) AT400517B (fi)
AU (1) AU647922B2 (fi)
CA (1) CA2068957C (fi)
CH (1) CH683823A5 (fi)
CY (1) CY1942A (fi)
CZ (2) CZ285275B6 (fi)
DE (1) DE4215450B4 (fi)
DK (1) DK0515310T3 (fi)
ES (1) ES2186668T3 (fi)
FI (2) FI102458B1 (fi)
FR (1) FR2676646B1 (fi)
GB (1) GB2255908B (fi)
HK (1) HK148896A (fi)
HU (1) HU223343B1 (fi)
IE (1) IE70913B1 (fi)
IL (1) IL101903A (fi)
IT (1) IT1260710B (fi)
LU (1) LU88114A1 (fi)
MX (1) MX9202328A (fi)
NO (1) NO180772C (fi)
PT (1) PT515310E (fi)
RO (1) RO111986B1 (fi)
SA (1) SA92130087B1 (fi)
SK (1) SK281615B6 (fi)
UA (1) UA39853C2 (fi)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
US6005001A (en) * 1991-05-20 1999-12-21 Novartis Ag (Formerly Sandoz Ag) Pharmaceutical composition
HU219480B (hu) * 1991-05-23 2001-04-28 Novartis Ag. Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
WO2000024377A1 (en) * 1998-10-23 2000-05-04 Idea Innovative Dermale Applikationen Gmbh Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates
ES2173679T3 (es) 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
ATE216875T1 (de) 1999-01-27 2002-05-15 Idea Ag Nichtinvasive impfung durch die haut
AU5409699A (en) * 1999-07-05 2001-01-22 Idea Ag A method for the improvement of transport across adaptable semi-permeable barriers
GB0001928D0 (en) * 2000-01-27 2000-03-22 Novartis Ag Organic compounds
GB0003932D0 (en) 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
DE10011081A1 (de) * 2000-03-09 2001-09-13 Aventis Pharma Gmbh Antiinfektive Wirkstoffkombinationen und ihre Verwendung zur topischen Behandlung von Pilzerkrankungen der Fuß- und Fingernägel
US7074392B1 (en) * 2000-03-27 2006-07-11 Taro Pharmaceutical Industries Limited Controllled delivery system of antifungal and keratolytic agents for local treatment of fungal infections
US8257688B2 (en) * 2000-03-27 2012-09-04 Taro Pharmaceuticals Industries Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
DE10035991A1 (de) 2000-07-24 2002-02-14 Polichem Sa Nagellackzusammensetzung
KR100389671B1 (ko) * 2000-11-24 2003-06-27 한미약품 주식회사 염산 테르비나핀을 함유하는 항진균제 외용 약제 조성물
US6490390B1 (en) * 2001-01-05 2002-12-03 Phaethon Communications Grating writing systems based on an acousto-optic element
GB0103046D0 (en) * 2001-02-07 2001-03-21 Novartis Ag Organic Compounds
KR100423666B1 (ko) * 2001-02-07 2004-03-18 보령제약 주식회사 항진균 외용 제제
GB0108082D0 (en) * 2001-03-30 2001-05-23 Novartis Consumer Health Sa Topical composition
BRPI0101486B1 (pt) * 2001-04-17 2017-09-19 Cristália Produtos Químicos Farmacêuticos Ltda. Pharmaceutical composition for topic use containing heparin for the treatment of skin or mucosal injuries caused by burns
US7244703B2 (en) 2001-06-22 2007-07-17 Bentley Pharmaceuticals, Inc. Pharmaceutical compositions and methods for peptide treatment
US20040105881A1 (en) * 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
NZ544851A (en) * 2003-06-23 2008-03-28 Macrochem Corp A vanishing cream base composition suitable for topical administration of an active agent to an animal or plant
JP5435836B2 (ja) * 2003-07-03 2014-03-05 大正製薬株式会社 外用抗真菌剤組成物
KR100581169B1 (ko) * 2003-07-07 2006-05-17 한국유나이티드제약 주식회사 용해도가 개선된 테르비나핀의 약제조성물 및 그 제조방법
JP2005104916A (ja) * 2003-09-30 2005-04-21 Kobayashi Pharmaceut Co Ltd 抗真菌組成物
CN1913912B (zh) 2003-12-08 2010-06-16 Cpex药品公司 用于胰岛素治疗的药用组合物及方法
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
US7854943B2 (en) * 2004-06-24 2010-12-21 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
WO2006003492A2 (en) * 2004-07-02 2006-01-12 Warner-Lambert Company Llc Compositions and methods for treating pathological infections
US7740875B2 (en) * 2004-10-08 2010-06-22 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
US20060078580A1 (en) * 2004-10-08 2006-04-13 Mediquest Therapeutics, Inc. Organo-gel formulations for therapeutic applications
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
WO2006103638A2 (en) * 2005-03-31 2006-10-05 Ranbaxy Laboratories Limited Topical pharmaceutical compositions of terbinafine and processes for their preparation
AU2006272766A1 (en) * 2005-07-21 2007-02-01 Nomir Medical Technologies, Inc. Near infrared microbial elimination laser system (NIMELS)
US7359057B2 (en) * 2005-08-26 2008-04-15 Ball Aerospace & Technologies Corp. Method and apparatus for measuring small shifts in optical wavelengths
NZ566401A (en) 2005-09-29 2011-03-31 Novartis Ag Topical antifungal compositions of terbinafine with hydroxypropylcellulose and an octylacrylamide acrylate copolymer
US20080167312A1 (en) * 2006-12-08 2008-07-10 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted allylamines
EP2120870A2 (en) * 2007-02-21 2009-11-25 Power Paper Ltd. Terbinafine formulation for iontophoresis
WO2008105038A1 (ja) * 2007-02-23 2008-09-04 Nichiban Company Limited 抗真菌症用貼付剤
WO2008121709A1 (en) * 2007-03-30 2008-10-09 Transport Pharmaceuticals, Inc. Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug
US20090082469A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched terbinafine
KR20110090892A (ko) * 2008-10-31 2011-08-10 모베르그 데르마 아베 두 개 이상의 침투 증강제의 조합으로 구성되는 국소 조성물
PT2735309T (pt) 2012-11-27 2016-09-26 Cos Alfonso Eduardo Composição farmacêutica para o tratamento da tendinite calcificada e/ou da bursite calcificada
US9446131B2 (en) 2013-01-31 2016-09-20 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9433680B2 (en) 2013-01-31 2016-09-06 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US9452173B2 (en) 2013-01-31 2016-09-27 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8778365B1 (en) 2013-01-31 2014-07-15 Merz Pharmaceuticals, Llc Topical compositions and methods for making and using same
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
JP2017536421A (ja) 2014-12-01 2017-12-07 アケリオス セラピューティクス，インコーポレーテッド 片頭痛及び疼痛に関連する状態を処置するための方法及び組成物
GB201511799D0 (en) * 2015-07-06 2015-08-19 Blueberry Therapeutics Ltd Composition and methods of treatment
CA3045004A1 (en) * 2015-12-16 2017-06-22 Achelios Therapeutics, Inc. Methods and compositions for treating peripheral neuropathy
TWI656883B (zh) * 2017-08-21 2019-04-21 高雄醫學大學 光敏劑或其前驅藥物的醫藥載體
WO2023225373A1 (en) * 2022-05-20 2023-11-23 Dermbiont, Inc. Compositions and formulations for use of a pk inhibitor for the prevention, treatment, and improvement of skin diseases, conditions, and disorders

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE2716943C2 (de) * 1976-04-28 1986-08-14 Sandoz-Patent-GmbH, 7850 Lörrach N-(3-Phenyl-2-propenyl)-N-(1-naphthylmethyl)-amine, ihre Verwendung und Herstellung
DE19375084I2 (de) * 1979-08-22 2000-11-16 Novartis Ag Propenylamine Verfahren zu ihrer Herstellung sie enthaltende pharmazeutische Zusammensetzungen und ihre Verwendung als Arzneimittel
FR2572933B1 (fr) * 1981-04-06 1988-03-18 Sandoz Sa Compositions pharmaceutiques topiques a base de tizanidine
FR2502951B1 (fr) * 1981-04-06 1985-12-06 Sandoz Sa Compositions pharmaceutiques topiques sous forme d'une micro-emulsion
JPS6058914A (ja) * 1983-09-12 1985-04-05 Shionogi & Co Ltd イミダゾ−ル系抗真菌性外用ゲル製剤
US4912124A (en) * 1984-02-23 1990-03-27 Ortho Pharmaceutical Corporation Antifungal dermatological solution
JPS61151117A (ja) * 1984-12-25 1986-07-09 Bayer Yakuhin Kk 抗真菌ゲル製剤
US4760096A (en) * 1985-09-27 1988-07-26 Schering Corporation Moisturizing skin preparation
JP2633555B2 (ja) * 1987-03-23 1997-07-23 株式会社東芝 半導体装置の製造方法
EP0325949B1 (en) * 1988-01-13 1991-12-18 Schwarz Pharma Ag Concentrated solutions of corticosteroids and method of making them
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
US5116603A (en) * 1989-01-31 1992-05-26 Yissum Research Development Company Of The Hebrew University Of Jerusalem Oral antifungal preventative, and method of use
HUT58201A (en) * 1989-03-03 1992-02-28 Sandoz Ag Process for producing antiphlogistic pharmaceutical composition containing naphtalene-methan-amino derivatives
FR2646603B1 (fr) * 1989-05-03 1991-07-12 Oreal Composition nettoyante
CA2020888A1 (en) * 1989-07-27 1991-01-28 Philippe Guerry Substituted aminoalkoxybenzene derivatives
FR2666962B1 (fr) * 1990-09-26 1996-06-14 Oreal Composition antifongique sous forme de spray sec.
FR2673537B1 (fr) * 1991-03-08 1993-06-11 Oreal Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes.
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására

Also Published As

Publication number Publication date
HU223343B1 (hu) 2004-06-28
KR920021139A (ko) 1992-12-18
DE4215450B4 (de) 2006-04-27
MX9202328A (es) 1994-04-29
FI102458B (fi) 1998-12-15
HUT62466A (en) 1993-05-28
IE921599A1 (en) 1992-12-02
CA2068957C (en) 2002-12-17
ITRM920361A0 (it) 1992-05-12
AU1631792A (en) 1992-11-26
CS149192A3 (en) 1992-12-16
ITRM920361A1 (it) 1993-11-12
FR2676646A1 (fr) 1992-11-27
FI102458B1 (fi) 1998-12-15
FR2676646B1 (fr) 1995-05-05
RO111986B1 (ro) 1997-04-30
HU9201518D0 (en) 1992-07-28
DE4215450A1 (de) 1992-11-26
EP0515310A1 (en) 1992-11-25
PT515310E (pt) 2003-03-31
LU88114A1 (fr) 1993-12-06
ATA102392A (de) 1995-06-15
NO921958L (no) 1992-11-23
EP0515310B1 (en) 2002-11-06
CY1942A (en) 1997-05-16
JP2651311B2 (ja) 1997-09-10
GB9210579D0 (en) 1992-07-01
CZ285275B6 (cs) 1999-06-16
CA2068957A1 (en) 1992-11-21
KR100303095B1 (ko) 2001-11-22
FI981777A (fi) 1998-08-18
US5856355A (en) 1999-01-05
IT1260710B (it) 1996-04-22
AT400517B (de) 1996-01-25
AU647922B2 (en) 1994-03-31
GB2255908B (en) 1995-10-04
SK281615B6 (sk) 2001-05-10
IL101903A (en) 1998-08-16
ES2186668T3 (es) 2003-05-16
NO180772C (no) 1997-06-18
JPH05132419A (ja) 1993-05-28
DK0515310T3 (da) 2003-03-03
CZ283019B6 (cs) 1997-12-17
NO921958D0 (no) 1992-05-18
NO180772B (no) 1997-03-10
GB2255908A (en) 1992-11-25
FI922252A0 (fi) 1992-05-18
US5681849A (en) 1997-10-28
IE70913B1 (en) 1997-01-15
HK148896A (en) 1996-08-16
FI922252A (fi) 1992-11-21
SA92130087B1 (ar) 2006-05-23
CH683823A5 (de) 1994-05-31
UA39853C2 (uk) 2001-07-16
IL101903A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A (fi) Farmaseuttinen ainekoostumus
FI921060A (fi) Farmaceutiska aerosolformuleringar
FI922316A (fi) Farmaceutisk sammansaettning
NO923127D0 (no) Farmasoeytisk kombinasjonsformulering
DK0585252T3 (da) Farmaceutiske formuleringer
FI944832A0 (fi) Farmaseuttinen koostumus
DE4291156T1 (de) Verbesserte pharmazeutische Zusammensetzungen
NO923859D0 (no) Medikament
BR9200058A (pt) Composto e composicao farmaceutica
MX9200622A (es) Composicion farmaceutica
ITMI932540A0 (it) Composizione farmaceutica
DE4294862T1 (de) Pharmazeutische Komposition
UA26064A1 (uk) Фармацевтичhа композиція
LV10579A (lv) Farmaceitiska kompozicija
FI934387A0 (fi) 3-substituerade 2-oxi-indol-1-karboxiamid omfattande farmaceutiska kompositioner
DE69225266D1 (de) Bis-bibenzimidazol Zusammensetzung
BR9202742A (pt) Composicao delimpeza
FI920845A (fi) Farmaceutiska kompositioner innehaollande interleukin-2
NO924484D0 (no) Pesticid sammensetning
FI925175A0 (fi) Kompositioner haerdbara medelst straolning
FI922185A (fi) Faergframkallande komposition
SE9101348D0 (sv) Pharmaceutical composition
SE9103213D0 (sv) Farmaceutisk komposition
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina